The question stops being "can I afford to start?" and becomes "can I afford to continue?" This article covers what the published data says about duration, what happens when people stop, what actually occurs in real-world practice (which turns out to be quite different from the trials), and why, for anyone paying cash, the monthly price becomes the single most consequential variable in the entire decision
Laboratory research record on GLP-1S [PMID: 39114239] PubMed laboratory record discussing GLP-1S in a research context
Severe gastrointestinal problems: Rare cases of severe gastroparesis or intestinal obstruction
And could they impact cancer outcomes in people diagnosed with the disease
These companies have extensive networks of pharmaceutical distributors for diabetes medications, ensuring that their products reach healthcare providers and patients nationwide
Oben J, Morgan L, Fletcher J, Marks V